The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Ansun Biopharma announced preliminary data from an investigator-initiated trial of DAS181, a recombinant sialidase with broad antiviral properties, ...
read more
PharmaMar has announced the APLICOV clinical trial protocol for Aplidin was submitted to the Spanish Medicines and Healthcare Products Agency.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Wednesday, April 08, 2020
I-Mab announced the FDA has cleared the Company's IND to initiate a clinical study for TJM2 to treat cytokine release syndrome associated with COVID-...
read more
Wednesday, April 08, 2020
As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two ...
read more
Wednesday, April 08, 2020
Review the latest news and information on the COVID-19 Pandemic.
read more
Akers announced its collaboration with Premas Biotech has successfully completed the milestone of obtaining clones of all three coronavirus antigens, ...
read more
Cytovia Therapeutics is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis.
read more
Kedrion Biopharma has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients in ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
The ISPE has announced the 2020 Facility of the Year Awards Category Winners—including two winners of the inaugural Social Impact Category Award.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
7 Hills announced the FDA has cleared the company’s IND application for 7HP349, a first-in-class, oral integrin activator that has the potential to ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more